Conference Coverage

Idiopathic pulmonary fibrosis a ‘robust diagnosis’


 

REPORTING FROM RHEUMATOLOGY 2018


“A very small number of patients with IPF actually have the presence of autoantibodies strongly associated with CTDs. This suggests IPF is a very robust diagnosis; chest physicians are diagnosing it correctly most of the time, and they are really good at good at weeding out those who have got IPF and those who have potentially got connective tissue disease.” Dr. Cotton concluded.

Dr. Cotton had no conflicts of interest.

SOURCE: Cotton CV et al. Rheumatology. 2018;57[Suppl. 3]:key075.206.

Pages

Recommended Reading

VIDEO: Skin exam crucial in rheumatic diseases, expert says
MDedge Rheumatology
VIDEO: Characteristic flora define intestinal microbiome in scleroderma
MDedge Rheumatology
VIDEO: Calming microglia might control fibromyalgia
MDedge Rheumatology
Newer IgG4 testing proving effective in assessing patients
MDedge Rheumatology
New agents may bring hope for SLE patients
MDedge Rheumatology
Caution crucial for stem cell transplant in scleroderma, despite potential interest
MDedge Rheumatology
Don’t trust interface dermatitis to diagnose dermatomyositis
MDedge Rheumatology
Median time to progression from discoid to systemic lupus may be less than a year
MDedge Rheumatology
Timely dermatomyositis diagnosis, treatment remain elusive
MDedge Rheumatology
Hydroxychloroquine throws off Quantiferon-TB Gold results, study finds
MDedge Rheumatology